Patent intelligence · US
US 7166584
Cholesterol transport gene
Cholesterol transport gene
Patent details — US 7166584
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 23, 2007
- Expiration
- Jan 18, 2027
- Applicant
- Xenon Genetics Inc.
- Claims
- 4
- CPC classes
- A61K, A61K31/64, A61K49/0008, A61P
Quick answer
US 7166584 (Cholesterol transport gene) is held by Xenon Genetics Inc.. Status: granted. Granted Jan 23, 2007. Expires Jan 18, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Xenon Genetics Inc.
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K31/64, A61K49/0008, A61P, A61P3/06
More from Xenon Genetics Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12319657
Solid state crystalline forms of a selective potassium channel modulator
granted -
US 12178811
Methods of treating depressive disorders
granted -
US 12171759
Methods and uses for treating anhedonia
granted -
US 11957675
Methods and uses for treating anhedonia
granted -
US 11325902
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
US 11299490
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
US 11203572
Substituted benzamides and methods of use thereof
granted -
US 11174268
Benzenesulfonamide compouds and their use as therapeutic agents
granted
Frequently asked questions
What is US patent 7166584?
US 7166584 (Cholesterol transport gene) is held by Xenon Genetics Inc.. Status: granted. Granted Jan 23, 2007. Expires Jan 18, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7166584?
Xenon Genetics Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 106 pharmaceutical patents for this assignee.
When does US 7166584 expire?
Our index shows an expiration date of Jan 18, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.